Invention Grant
- Patent Title: Cyclopropylamines as LSD1 inhibitors
-
Application No.: US16897051Application Date: 2020-06-09
-
Publication No.: US11247992B2Publication Date: 2022-02-15
- Inventor: Liangxing Wu , Joel R. Courter , Chunhong He , Xiaozhao Wang , Wenqing Yao , Fenglei Zhang
- Applicant: Incyte Corporation
- Applicant Address: US DE Wilmington
- Assignee: Incyte Corporation
- Current Assignee: Incyte Corporation
- Current Assignee Address: US DE Wilmington
- Agency: Fish & Richardson P.C.
- Main IPC: A61K31/397
- IPC: A61K31/397 ; C07D471/10 ; C07D205/04 ; C07D211/58 ; A61K31/4468 ; A61K31/435 ; C07D401/06 ; A61K31/4523 ; C07D211/34 ; A61K31/445 ; C07D211/32 ; A61K31/454 ; A61K31/497 ; A61K31/506 ; C07D401/12 ; C07D211/14 ; C07D211/16 ; A61K45/06
Abstract:
The present invention is directed to cyclopropylamine derivatives which are LSD1 inhibitors useful in the treatment of diseases such as cancer.
Public/Granted literature
- US20210032244A1 CYCLOPROPYLAMINES AS LSD1 INHIBITORS Public/Granted day:2021-02-04
Information query
